In the second quarter, Germany said it planned to receive 16 million doses of AstraZeneca’s coronavirus vaccine, the Ministry of Health said.
This may constitute a deficit in the company’s pledge to supply approximately twice the amount of doses to Germany in that quarter under the leaked EU contract.
On Tuesday, Reuters announced that supply volumes to the European Union were projected to be at half the amount contracted for delivery in the second quarter by AstraZeneca.
According to the German Ministry of Health’s internal document seen by Reuters and the leaked contract between AstraZeneca and the EU, Germany’s 16 million doses are in line with this possible shortfall because the country was expected to receive about 34 million shots of the 180 million AstraZeneca agreed to supply the EU in the second quarter.
The Ministry of Health stated in its statement on Wednesday the German estimates for deliveries contained in the internal text, which were not previously made public.
According to the document dated 22 February, in the third quarter, Germany is scheduled to receive 33.8 million doses of AstraZeneca, beyond the timetable set in the EU deal, which allows for initial deliveries to be completed by the end of June.
In total, Germany expects 56.3 million doses from AstraZeneca under the EU contract, equivalent to 18.7 percent of the EU’s 300 million doses.
The Health Ministry has always taken into account that the AstraZeneca vaccine was approved later than we intended it to be in the fall when estimating the number of doses available to regions, the Health Ministry said.